Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
Dimethyloxalylglycine (DMOG): Practical Use and Protocols
2026-05-26
Dimethyloxalylglycine (DMOG) enables researchers to stabilize hypoxia-inducible factor (HIF-1α) in both in vitro and in vivo models, providing a reliable tool for hypoxia, inflammation, and infection studies. DMOG should not be used in diagnostic or clinical applications; its technical use requires careful attention to solubility and storage to ensure reproducible results.
-
Oligo (dT) 25 Beads: Reliable Magnetic mRNA Isolation in Pra
2026-05-26
This article addresses real laboratory challenges in eukaryotic mRNA isolation, highlighting how Oligo (dT) 25 Beads (SKU K1306) from APExBIO provide reproducible, high-purity results across diverse workflows. Scenario-driven Q&As, protocol tips, and literature context equip biomedical researchers and technicians with actionable strategies for robust mRNA purification.
-
Localized BDNF Release Orchestrates Early NMJ Postsynaptic A
2026-05-25
This study uncovers how spatially controlled, muscle-generated BDNF regulates the initial formation of acetylcholine receptor clusters at neuromuscular junctions through tightly orchestrated trafficking and proteolytic processing. The findings clarify the interplay between intracellular BDNF handling, localized vesicular release, and matrix metalloproteinase activity, with direct implications for experimental manipulation of synaptic development.
-
Dextran Sulfate Sodium Salt: Optimizing Mouse IBD Model Work
2026-05-25
Dextran sulfate sodium salt (MW 35000-45000) remains the gold standard for inducing experimental colitis in mice, enabling the detailed study of mucosal damage and repair. Recent mechanistic insights, including GPR35-KLF5 signaling, now empower researchers to refine DSS-based protocols for translational advances in ulcerative colitis.
-
U-73122: A Selective Phospholipase C Inhibitor for PLC Pathw
2026-05-24
U-73122 is a potent phospholipase C inhibitor with selective affinity for the PLC-β2 isoform. It disrupts PIP2 hydrolysis and downstream signaling, thereby modulating calcium flux and chemotaxis in cellular models. U-73122 provides a validated tool for dissecting PLC-dependent signaling in research on inflammation, cancer, and cell migration.
-
Cy3-UTP: Illuminating RNA Spatial Organization in the Nucleu
2026-05-23
This article explores how Cy3-UTP empowers researchers to visualize the spatial organization of actively transcribed RNAs—highlighting new mechanistic insights into nuclear speckle assembly derived from recent studies. We blend biological rationale, hands-on protocol guidance, and translational strategy, drawing on APExBIO’s Cy3-modified uridine triphosphate to showcase the next frontier in RNA-protein interaction studies and high-sensitivity RNA imaging.
-
Oligo (dT) 25 Beads: Epigenetic Insights for Advanced mRNA P
2026-05-22
Explore how Oligo (dT) 25 Beads offer unparalleled precision in eukaryotic mRNA isolation, integrating recent epigenetic findings to optimize downstream assays. Discover expert guidance on leveraging superparamagnetic beads for robust molecular biology workflows.
-
Species-Specific HD56 Prodrug Metabolism: The Role of Humani
2026-05-22
This study establishes humanized liver mice as a critical model for evaluating the in vivo metabolism and pharmacokinetics of HD56, a carboxylate ester prodrug targeting FK506 binding proteins. The research provides robust evidence that species differences in carboxylesterase-mediated activation can be effectively bridged by humanized models, improving translational accuracy for neuroprotective prodrugs.
-
BRCA1/BARD1–pre-rRNA Interaction Drives Homologous Recombina
2026-05-21
Wu et al. (2023) uncover a direct mechanistic link between the BRCA1/BARD1 DNA repair complex and pre-ribosomal RNA (pre-rRNA), showing that pre-rRNA recognition is essential for homologous recombination. This discovery advances understanding of how genome stability is maintained and suggests new avenues for targeting DNA repair in cancer therapy.
-
c-Myc tag Peptide: Enhanced Immunoassay Precision & Troubles
2026-05-21
The c-Myc tag Peptide unlocks precise displacement of c-Myc-tagged fusion proteins in immunoassays, driving reliable antibody binding inhibition and streamlined workflow optimization. Explore how this APExBIO reagent enables advanced applications, robust troubleshooting, and actionable protocol parameters for transcription factor and cell proliferation research.
-
Targeting PLPP1 to Overcome Cisplatin Resistance in Lung Can
2026-05-20
The reference study demonstrates that combining Z-ligustilide with cisplatin counteracts cisplatin resistance in lung cancer cells by modulating PLPP1-mediated phospholipid synthesis. This mechanistic insight offers a novel approach for sensitizing resistant tumors and provides a framework for transcriptome-driven therapeutic strategies.
-
Norovirus Exploits NINJ1 for Selective Viral Protein Secreti
2026-05-20
This study uncovers how murine norovirus hijacks the host membrane protein NINJ1 to achieve selective secretion of its NS1 protein via an unconventional pathway. These findings illuminate a novel intersection between programmed cell death, membrane rupture, and viral immune evasion, providing new insights into host-pathogen interactions.
-
Quizartinib (AC220): Transforming FLT3 Pathway Research in A
2026-05-19
This thought-leadership article explores how Quizartinib (AC220), a highly selective FLT3 inhibitor from APExBIO, is redefining acute myeloid leukemia (AML) research. Integrating mechanistic insights, strategic guidance for translational researchers, and recent evidence on FLT3-driven resistance, it charts new directions for experimental design and clinical translation—bridging the gap between preclinical rigor and therapeutic innovation.
-
Localized BDNF Release Regulates Early NMJ Postsynaptic Asse
2026-05-19
This study reveals how muscle-generated BDNF is spatially trafficked and locally released to control the formation of postsynaptic acetylcholine receptor clusters at neuromuscular junctions. The findings illuminate the mechanisms underlying activity-dependent BDNF processing and highlight the critical role of local proteolytic conversion—including MMPs—in early synaptic assembly, with implications for both neuromuscular research and targeted intervention strategies.
-
Streptavidin – Cy5: High-Sensitivity Biotin Detection for Re
2026-05-18
Streptavidin – Cy5 is a tetrameric fluorescent probe enabling high-affinity, four-site biotin detection in immunofluorescence, immunohistochemistry, and flow cytometry. Its Cy5 conjugation delivers robust sensitivity, reproducibility, and spectral separation for multiplexed assays. APExBIO's formulation is widely adopted in translational oncology and cell-based workflows.